Posted in | News

Foster Wheeler Wins Gulf Farabi Petrochemical's Plant Expansion Contract in Saudi Arabia

Foster Wheeler AG (Nasdaq: FWLT) announced today that its Global Engineering and Construction Group has been awarded a contract by Gulf Farabi Petrochemical Company for the provision of project management consultancy (PMC) services for Gulf Farabi’s Linear Alkyl Benzene (LAB) plant expansion at Al-Jubail, Saudi Arabia.

The Foster Wheeler contract value for this project was not disclosed and was included in the company’s first-quarter 2010 results.

The new plant will have a production capacity of 100,000 tonnes per annum of LAB which is a basic ingredient in the formulation of synthetic detergents.

The first phase of the project covers the preparation and issue of an invitation to bid (ITB) for the engineering, procurement and construction management (EPCm), EPCm bid evaluations, preparation of the EPCm contract and support to Gulf Farabi during the engineering and procurement phase of the project. For the second phase, Foster Wheeler will provide support to Gulf Farabi during the construction phase, with key personnel based at site in 2010 through to 2011 when the project is scheduled for completion.

“Following on from our successful PMC role during the EPC phase of Gulf Farabi’s US$350 million grass roots n-paraffin and LAB project which came on-stream in 2006, we are very pleased to receive this latest contract which constitutes a strong vote of confidence in our project management skills,” said Umberto della Sala, president and chief operating officer, Foster Wheeler AG.

“Foster Wheeler’s contribution to our previous project is commendable and we are going ahead with this winning combination for our expansion project,” commented Mohammed Al-Bibi, president, Gulf Farabi Petrochemical Company Limited.

Source: http://www.fwc.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.